PAX6 and glioblastoma: PAX6 has been showed to inhibit WNT5A-mediated glioblastoma stem cell (GSC) differentiation into endothelial-like cells, where silencing of PAX6 by activation of the AKT- pathway increased proliferation, vascularization, and invasive growth [22].